Related Experiment Video
Updated: Mar 29, 2026

DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis
Published on: October 6, 2017
Harnessing TLS polymerases to direct nucleotide outcomes in base editing
None:
Base editors introduce defined DNA lesions rather than directly rewriting nucleotides, and these lesions must be processed by cellular DNA repair pathways. In glycosylase-mediated base editing, apurinic/apyrimidinic sites (AP sites) represent a critical decision point where the choice of repair pathway determines whether the outcome is a desired substitution or an unintended byproduct. Although product heterogeneity has long been considered an intrinsic limitation of base editing, recent mechanistic studies suggest competition among repair polymerases represents a major contributor. Evidence indicates translesion synthesis polymerases can serve as tunable resolvers by preferentially inserting specific nucleotides opposite AP sites. Engineering their recruitment and insertion preferences may shift base editing from a stochastic repair-dependent process toward a more predictable mode of nucleotide incorporation.
More Related Videos
09:26DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
Published on: December 29, 2021
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Proofreading
Errors During Replication are Corrected by the DNA Polymerase...
Proofreading
Long-patch Base Excision Repair
Base Excision Repair
The first step of...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...